Mode
Text Size
Log in / Sign up
N/A Completed N=8 Supportive Care

Telehealth-Clinical Advocacy Project

Source: ClinicalTrials.gov NCT04911426 ↗
Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcomePrimary: Percent of Participants Who Received One or More Referrals During the 12-week Intervention. — 4 Participants

Summary

The purpose of this study is to develop a clinical telehealth intervention and test the feasibility of integrating telehealth within a police opioid county diversion program.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percent of Participants Who Received One or More Referrals During the 12-week Intervention.
4
PRIMARY
Texas Christian University Drug Screen 5 Severity Score From Baseline to Post Intervention at Week 12
9.25; 9.75

Eligibility Criteria

Inclusion Criteria

Individuals interested in joining the study will be

  • Enrolled in the A Way Out Opioid Diversion Program (ODP),
  • At least 18 years of age,
  • Able to speak and understand English,
  • Have a history of opioid, alcohol, or other substance use within last 12 months,
  • Be willing to provide the research team with access to treatment records,
  • Have access to a phone, tablet or computer for the informed consent activity, and
  • Have a mailing address to receive a study phone issued to consented participants

Exclusion Criteria

Individuals not eligible for the study are

  • Not currently enrolled in the A Way Out Opioid Diversion Program on the day of consent,
  • Under the age of 18 on the day of consent,
  • Unable to speak and understand English,
  • Have a history of past opioid, alcohol, or other substance use longer than 12 months ago with no use of opioids in the last 12 months,
  • Unwilling to authorize the research team to access treatment records,
  • Without access to a phone, tablet or computer to complete the informed consent activity,
  • Without a mailing address
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04911426). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search